Immuneering Corporation

IMRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.58

+$0.14 (+3.15%)

Sep 22, 2026, 10:46 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	n/a	n/a	n/a	316.95K	2.08M	2.31M
Cost of Revenue	698.89K	n/a	n/a	158.12K	1.15M	1.28M
Gross Profit	-698.89K	n/a	n/a	158.83K	926.89K	1.03M
Operating Income	-59.38M	-64.07M	-58.41M	-51.74M	-33.89M	-17.08M
Interest Income	3.04M	2.59M	3.61M	1.01M	169.9K	42.66K
Pretax Income	-56.02M	-61.04M	-53.47M	-50.51M	-33.84M	-17.12M
Net Income	-56.02M	-61.04M	-53.47M	-50.51M	-33.54M	-17.04M
Selling & General & Admin	17.3M	16.08M	16.76M	15.61M	8.27M	3.11M
Research & Development	42.05M	47.96M	41.62M	36.27M	26.54M	15M
Other Expenses	-669.62K	29.01K	28.87K	29.58K	n/a	n/a
Operating Expenses	58.68M	64.07M	58.41M	51.9M	34.81M	18.11M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	59.38M	64.07M	58.41M	52.06M	35.97M	19.39M
Income Tax Expense	n/a	n/a	n/a	n/a	-307.49K	-84.34K
Shares Outstanding (Basic)	44.01M	29.98M	28.42M	26.39M	26.32M	13.51M
Shares Outstanding (Diluted)	44.01M	29.98M	28.42M	26.39M	26.32M	13.51M
EPS (Basic)	-1.27	-2.04	-1.88	-1.87	-1.27	-1.26
EPS (Diluted)	-1.27	-2.04	-1.88	-1.87	-1.27	-1.26
EBITDA	-55.33M	-63.69M	-58.06M	-51.47M	-33.68M	-17M
EBIT	-56.02M	-64.07M	-58.41M	-51.75M	-33.84M	-17.08M
Depreciation & Amortization	698.89K	385.07K	352.08K	277.25K	159.07K	79.31K